Atlas Trials

Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients

Clinical trial NCT07074457 · RECRUITING

Trial details

NCT number
NCT07074457
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CD30+ Peripheral T-cell Lymphoma
Start date
2024-11-01
Primary completion
2028-08-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.